-
公开(公告)号：US20210355213A1
公开(公告)日：2021-11-18
申请号：US17381418
申请日：2021-07-21
Applicant: INNATE PHARMA
Inventor： HATEM ABDELAZIM , CARINE PATUREL
IPC: C07K16/28 , A61K31/7068 , A61K31/282 , G01N33/574 , A61K39/395 , A61P35/00
Abstract: The present invention relates to methods for the treatment of T cell lymphomas using compounds that specifically bind KIR3DL2 in combination with chemotherapeutic agents, notably gemcitabine and/or oxaliplatin. The treatments are particularly useful in the treatment of peripheral T cell lymphomas, for example PTCL-NOS.
Search Results
1
records
(took 0.009 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
